Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? – a meta-analysis of randomized controlled trials

R. Christensen, E.M. Bartels, R.D. Altman, A. Astrup, H. Bliddal

This review investigates Rosa canina (rosehip) preparation for symptomatic treatment of osteoarthritis (OA), in order to estimate the empirical efficacy as a pain reducing compound.  RCTs from systematic searches were included if they explicitly stated that OA patients were randomized to either rosehip or placebo. The primary outcome was reduction in pain calculated as effect size (ES), defined as the standardized mean difference (SMD). The three studies showed a reduction in pain scores by rosehip powder compared to placebo.

Although based on a sparse amount of data, the results of the present meta-analysis indicate that rosehip powder does reduce pain.

Osteoarthritis and Cartilage, 2008, 16(9), 965-972

Link to Abstract

Gluteal tendinopathy

Join Alison Grimaldi and Bill Vicenzino in this short online course for a review of the results and clinical implications of the LEAP trial.